Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines-Reference-Cited by-同舟云学术

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines

Published:2021-07 Issue: Volume:37 Page:100976
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Pitisuttithum Punnee,Dhitavat Jittima,Sirivichayakul Chukiat,Pitisuthitham Arom,Sabmee Yupa,Chinwangso Pailinrut,Kerdsomboon Chawanee,Fortuna Librada,Spiegel Jane,Chauhan Mukesh,Poredi Indrajeet Kumar,van den Biggelaar Anita H.J.,Wijagkanalan Wassana,Viviani Simonetta,Mansouri Souad,Pham Hong Thai

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. World Health Organization (WHO). WHO SAGE pertussis working group. Background paper SAGE April 2014. Available at: http://www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf. Accessed 2 Oct 2019.

2. Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines;Esposito;Front Immunol,2019

3. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis;Taranger;J Infect Dis,2000

4. Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons;Nguyen;Sci Adv,2020

5. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies;Ibsen;Vaccine,1996

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence;International Journal of Infectious Diseases;2024-07

2. Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines;Vaccine;2024-01

3. Antibody and B-cell Immune Responses Against Bordetella Pertussis Following Infection and Immunization;Journal of Molecular Biology;2023-12

4. A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women;Vaccine;2023-07

5. Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial;The Lancet;2023-03